Possible carcinogenesis of tumor suppressor let-7

Medical Hypotheses

Volumn 81, Issue 3, 2013, Pages 410-413

  Sun, Xin ^a   Fan, Chong ^a   Du, Ning ^a   Ren, Hong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MICRORNA; MICRORNA LET 7; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER RESEARCH; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE TARGETING; HUMAN; HYPOTHESIS; LIVER CELL CARCINOMA; NEGATIVE FEEDBACK; ONCOGENE C MYC; POSITIVE FEEDBACK; TUMOR SUPPRESSOR GENE; UPREGULATION;

FEEDBACK, PHYSIOLOGICAL; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; ONCOGENES;

EID: 84881542638     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.05.033     Document Type: Article

References (42)

1. Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
2. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011, 313-319.
3. Ito K., Bernardi R., Morotti A., et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 2008, 453:1072-1078.
4. Shachaf C.M., Kopelman A.M., Arvanitis C., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004, 431:1112-1117.
5. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
6. Thornton J.E., Gregory R.I. How does Lin28 let-7 control development and disease?. Trends Cell Biol 2012, 22:474-482.
7. He X.Y., Chen J.X., Ou-Yang X., Zhang Z., Peng H.M. Construction of let-7a expression plasmid and its inhibitory effect on k-Ras protein in A549 lung cancer cells. Nan Fang Yi Ke Da Xue Xue Bao 2010, 30:2427-2431.
8. Sun X., Qin S., Fan C., Xu C., Du N., Ren H. Let-7: A regulator of the ERalpha signaling pathway in human breast tumors and breast cancer stem cells. Oncol Rep 2013, 29:2079-2087.
9. Büssing I., Slack F.J., Großhans H. Let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 2008, 14:400-409.
10. Johnson C.D., Esquela-Kerscher A., Stefani G., et al. The let-7 MicroRNA represses cell proliferation pathways in human cells. Cancer Res 2007, 67:7713-7722.
11. DeSano J., Xu L. MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J 2009, 11:682-692.
12. Sun X., Fan C., Hu L.J., Du N., Xu C.W., Ren H. Role of let-7 in maintaining characteristics of breast cancer stem cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2012, 28:789-792.
13. Love T.M., Moffett H.F., Novina C.D. Not miR-ly small RNAs: big potential for micrornas in therapy. J Allergy Clin Immunol 2008, 121:309-319.
14. Sandhu S., Garzon R. Potential applications of MicroRNAs in cancer diagnosis, prognosis, and treatment. Semin oncol 2011, 38:781-787.
15. Si M.L., Zhu S., Wu H., Lu Z., Wu F., Mo Y.Y. MiR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
16. Kumar M.S., Erkeland S.J., Pester R.E., et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 2008, 105:3903-3908.
17. Liu C., Kelnar K., Vlassov A.V., Brown D., Wang J., Tang D.G. Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 2012, 72:3393-3404.
18. Trang P., Medina P.P., Wiggins J.F., et al. Regression of murine lung tumors by the let-7 microRNA. Oncogene 2010, 29:1580-1587.
19. Tsang J., Zhu J., van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell 2007, 26:753-767.
20. Chen A.X., Yu K.D., Fan L., et al. Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet 2011, 7:e1002259.
21. Rybak A., Fuchs H., Smirnova L., et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 2008, 10:987-993.
22. Sakurai M., Miki Y., Masuda M., et al. LIN28: A regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer. J Steroid Biochem Mol Biol 2012, 131:101-106.
23. Newman M.A., Thomson J.M., Hammond S.M. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 2008, 14:1539-1549.
24. Piskounova E., Polytarchou C., Thornton James E., et al. Lin28A and Lin28B Inhibit let-7 MicroRNA biogenesis by distinct mechanisms. Cell 2011, 147:1066-1079.
25. Bellosta P., Gallant P. Myc function in drosophila. Genes Cancer 2010, 1:542-546.
26. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. C-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
27. Sampson V.B., Rong N.H., Han J., et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007, 67:9762-9770.
28. Liu Y., Yin B., Zhang C., Zhou L., Fan J. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. Biochem Biophys Res Commun 2012, 417:371-375.
29. Koscianska E., Baev V., Skreka K., et al. Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Mol Biol 2007, 8:79.
30. Chang T.C., Yu D., Lee Y.S., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008, 40:43-50.
31. Gunaratne P.H. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?. Curr Stem Cell Res Ther 2009, 4:168-177.
32. Chang T.C., Zeitels L.R., Hwang H.W., et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci USA 2009, 106:3384-3389.
33. Zhao Y., Deng C., Wang J., et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat 2011, 127:69-80.
34. Klinge C.M. Estrogen regulation of MicroRNA expression. Curr Genomics 2009, 10:169-183.
35. Klinge C.M. MiRNAs and estrogen action. Trends Endocrinol Metab 2012, 23:223-233.
36. Ma X., Becker Buscaglia L.E., Barker J.R., Li Y. MicroRNAs in NF-κB signaling. J Mol Cell Biol 2011, 3:159-166.
37. Drost J., Agami R. Transformation locked in a loop. Cell 2009, 139:654-656.
38. Iliopoulos D., Hirsch H.A., Struhl K. An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009, 139:693-706.
39. Iliopoulos D., Hirsch H.A., Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009, 139:693-706.
40. Arora H., Qureshi R., Jin S., Park A.K., Park W.Y. MiR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp Mol Med 2011, 43:298-304.
41. Zhang R., He Y., Zhang X., et al. Estrogen receptor-regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocarcinoma and precancerous lesions. Cancer Lett 2012, 314:155-165.
42. Tsang W.P., Kwok T.T. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 2008, 13:1215-1222.